Behavioral Health ECHO - MAT & Opioid Use Treatment When Working with Pregnant Patients
If you are interested in participating, please email email@example.com.
Primary care physicians, nurses, mental health professionals, substance use disorder professionals, or clinic staff who support behavioral health services.
Led by a panel of behavioral health experts, Behavioral Health ECHO helps participants learn best practices for treating common mental health conditions and connect with peers from around the state to discuss and learn best practices in identifying and treating behavioral health issues. The curriculum is delivered at no cost through case-based learning strategies via video conferencing technology.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live, online activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.5 continuing education contact hour(s). No partial credit awarded.
- Other Healthcare Professionals: This live activity is designated for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.
No ineligible company provided financial support for this continuing education activity.
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Julie Baker, MPA, CHCEF - Planning Committee Member
- Kristi Barslou - Activity Coordinator and Moderator
- Tiffany Conroy, LISW - Moderator
- Bery Engebretsen, MD - Activity Director
- Nicolas Foss, EdD, MS, IADC, ICGC-II, BACC - Moderator
- Nicole Gastala, MD - Planning Committee Member
- Janice Landy, MD - Planning Committee Member
- Danielle O'Brien-Day, LMHC, NCC - Planning Committee Member
- Elizabeth Rosa - Activity Coordinator and Moderator
- Andrea Storjohann MSN, ARNP, PMHNP-BC, CADC - Planning Committee Member
- Megan Westerly, MSN, RN - Activity Director, Coordinator, Planning Committee Member, Moderator
The information provided in this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.50 AMA PRA Category 1 Credits™
- 1.50 AOA Category 2A
- 1.50 CE Contact Hour(s)
- 1.50 IBON